Skip to main content

Table 1 Patient characteristics

From: Adjuvant radiotherapy and chemoradiation with gemcitabine after R1 resection in patients with pancreatic adenocarcinoma

Patient characteristics

Values

Number

25

Gender

   Male

17 (68%)

   Female

8 (32%)

Age (years)

   Median, range

60 (34 to 74)

Localization

   Head

21

   Body and/or tail

4

Lymph node status

   Positive

16 (64%)

   Negative

9 (36%)

Grading

   G1

0

   G2

11

   G3

11

   G4

1

   Not reported

2a

RTX

EBRT median dose (range) (n = 26)

49.6 Gy (36 to 54 Gy) RT

IORT median dose (range) (n = 7)

IORT: 12 Gy (10 to 15 Gy)

Concomitant CTX

   Overall (with gemcitabine)

23 (92%)

   None

2 (8%)

Toxicity

   Gastrointestinal (I to III°)

17

   Haematological (I° to IV°)

17

   Grade II

11

   Grade III

5

   Grade IV

1

Previous tumour resection

None

Duration resection - onset of RT

   Median, range [days]

44 (12 to 100)

   <30 days

5

   30 to 50 days

11

   >50 days

9

  1. RT radiotherapy, Gy grey, IORT intraoperative radiotherapy, CTX chemotherapy, EBRT external beam radiotherapy. aExplanation in ‘Patients and methods’ section.